Alnylam, Moderna Agree To COVID Vax Patent Judgment - Law360

Alnylam, Moderna Agree To COVID Vax Patent Judgment – Law360

Source Node: 2845400
By Lauren Berg (August 25, 2023, 11:20 PM EDT) -- Alnylam Pharmaceuticals Inc. and Moderna Inc. on Friday agreed to a final judgment of noninfringement in Alnylam's lawsuit alleging Moderna used patented biotechnology for its Spikevax coronavirus vaccine, following a Delaware federal judge's claim construction ruling, which Alnylam has vowed to appeal....

Time Stamp:

More from Law 360